News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Investing.com -- The United Arab Emirates reported to OPEC that its oil production increased by 80% in June after leaving the producer group, according to a monthly report seen by Bloomberg on Monday.
American Express Earns UpgradeJPMorgan has upgraded American Express (NYSE:AXP) to Overweight in its second-quarter consumer finance outlook, identifying the company as its preferred name in the sector despite mounting geopolitical and economic uncertainty. American Express shares rose around 1% in premarket trading following the analyst upgrade.
SanDisk, Micron, Digital Turbine and HPE surge more than 100% YTD but still trade below the tech sector's forward P/E average.
DELL, Brinker International, Tapestry and Alcon pair strong interest coverage with solid growth prospects amid elevated borrowing costs.
Investing.com -- Jefferies on Monday has upgraded Shopify to Buy from Hold and raised its price target to $160 from $140, saying the e-commerce platform is well positioned to benefit from the rise of agentic AI commerce while expecting stronger-than-consensus second-quarter results and additional growth catalysts over the next year.
FE, AEE, KO and NYT stand out as low-beta defensive stocks as renewed U.S.-Iran tensions, higher oil prices and market volatility raise demand for stability.
SLB secures one of the subsea industry's largest umbilical contracts, reinforcing its deepwater leadership through the Kutei North Hub project.
The constant barrage of artificial intelligence driving the hyperscaler complex massive spending spree is starting to fatigue many investors. With a war still in progress, albeit on a regional basis, in two sections of the world and government spending exploding the deficit higher, many across Wall Street are starting to agree that something has to ... The Market Could Crack This Summer: 5 Defensive High-Yielding Dividend Stocks to Buy Now
The social commerce market in Argentina is experiencing rapid growth, with the market projected to expand from $27.13 billion in 2025 to $45.71 billion by 2031, driven by an annual growth rate of 8.6%. This growth highlights increasing opportunities across various social platforms, distinct payment methods, and consumer segments. The comprehensive report provides strategic insights and over 50 key performance indicators (KPIs) to help stakeholders understand emerging trends and consumer...
Meta Increases Scale of Louisiana AI ProjectMeta (NASDAQ:META) has unveiled a major expansion of its Hyperion data centre in Richland Parish, Louisiana, increasing its planned computing capacity to 5 gigawatts while lifting total investment in the project to more than $50 billion. The facility had previously been expected to deliver more than 2 gigawatts of computing power to support the training of large language models used in generative AI applications such as ChatGPT.
Here is a way to collect an upfront income stream from one of the market's hottest stocks, which you keep no matter what, while lining up a chance to buy it at a serious discount if it ever pulls back.
Investing.com -- Truist Securities upgraded Biogen to Buy from Hold and raised its price target to $235 from $190, citing growing confidence in the company’s Alzheimer’s and immunology pipeline ahead of several major clinical data readouts over the next two years.
Johnson & Johnson (NYSE:JNJ) is the easiest healthcare name to evaluate on the board heading into its July 15 earnings release, and the setup leaves little to debate. The stock has already told you what it thinks of the fundamentals, rising nearly 25% year to date and nearly 66% over the past year. Yet the ... The Real Case for Buying Johnson & Johnson (JNJ) Before July 15
(Bloomberg) -- Walt Disney Co. shares have been in a slump for years, but Wells Fargo Securities said there’s one possible move that could reverse the trend: ditching its streaming-video business.Most Read from BloombergLindsey Graham, Senate Hawk Turned Trump Ally, Dies at 71Hormuz Route Open Despite Iran Declaration, Maritime Group SaysOpenAI Engineer’s ‘LOL’ Moment Set Stage for Legal Fight With AppleTrump Embraces Australian Retirement System Backed by Larry FinkUS Renews Iran Strikes as Bot
Applied Materials commands 24.7% net margins while Amkor trades at a fraction of the valuation, but customer concentration and export risks reshape the equation.
MU, UNH and SJM highlight recent gains across Zacks portfolios as the firm showcases performance amid mixed markets.
Biogen stock receives a bullish upgrade based on expectations the market will cheer the company’s detailed data on its experimental Alzheimer’s drug.
The telecom giant reports earnings next week.
Intuitive Surgical (NASDAQ:ISRG) looks compelling ahead of its July 16 earnings report, and the setup rarely gets this clean for a category leader trading well below fair value. Shares sit at $413.58, down 26.71% YTD, while the 247 base-case target of $559.79 implies 35.35% upside. Wall Street sits higher still at $563.35, with 22 buy ... Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16
Intel will invest €5bn to expand semiconductor manufacturing in Ireland as the US chipmaker seeks to grow production of processors used in AI...
SK Hynix's record $26.5B U.S. IPO and AI memory leadership put semiconductor, South Korea and IPO ETFs like SOXX, SMH, QQQ, EWY, IPO and FPX in focus.
KB Financial (KB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Wall Street analysts handed out surprise upgrades and painful downgrades on Monday, shifting outlooks for companies ranging from a pizza chain to a crypto-adjacent fintech as second-quarter earnings season prepares to kick off against a backdrop of Iran strikes and surging Treasury yields.
The chipmaker's June sales hit a record NT$442.68 billion, pushing second-quarter revenue above the top end of its own guidance
Agenus is financially abandoning an ongoing study in late-line colorectal cancer. Elsewhere, an ebola vaccine began human testing and an important Bristol Myers medicine got an FDA decision date.
June up 68%, first-half revenue near $75 billion, and the whole industry’s ambitions still running through one very busy island
Markets were subdued ahead of a busy week for markets, with inflation reports, bank earnings, and geopolitical risk hanging in the balance.
Own ASML Holding (NASDAQ:ASML) before the opening bell on July 15 when the company reports Q2 results and almost certainly reiterates a raised full-year outlook the market is still underpricing. The thesis rests on the fact that ASML is the only company on earth that sells EUV lithography, at a moment when its own CFO ... This Is Why ASML Is a No-Brainer Buy Before July 15 Earnings